Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Hypoxia-inducible factors (HIFs) were originally described as transcription factors that promote transcriptional responses during hypoxia adaptation (for example, increased erythropoietin release following blood loss or during hypoxia). More recently, it has been appreciated that HIFs are also active during a wider range of disease co...
Alternative Titles
Full title
Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4259899
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4259899
Other Identifiers
ISSN
1474-1776,1474-1784
E-ISSN
1474-1784
DOI
10.1038/nrd4422
